US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist
  • 359.960
  • -4.140-1.14%
Close Dec 27 16:00 ET
  • 360.000
  • +0.040+0.01%
Pre 04:34 ET
16.07BMarket Cap15.82P/E (TTM)

United Therapeutics Key Stats

United Therapeutics Q3 2024 Earnings Date

Currency:USDOct 30, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
722.57M
748.90M
+26.33M
Beat Est.
+18.57%
+22.89%
+3.64%
EPS
6.42
6.39
-0.03
Miss Est.
+19.41%
+18.77%
-0.54%
Strong Buy

Dec 29, 2024

United Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 757.420M--
--2024/Q4-- / 743.007M--
Oct 30, 20242024/Q3748.900M / 722.574M--
Jul 31, 20242024/Q2714.900M / 691.867M--
May 1, 20242024/Q1677.700M / 624.194M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 757.420M--
--2024/Q4-- / 743.007M--
Oct 30, 20242024/Q3748.900M / 722.574M--
Jul 31, 20242024/Q2714.900M / 691.867M--
May 1, 20242024/Q1677.700M / 624.194M--

Unlock Free Earnings Estimates

United Therapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 29, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data